Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury: Is it a new drug for modulation of systemic inflammatory response

Burns

Volumn 34, Issue 1, 2008, Pages 104-108

  Eski, Muhitdin ^a   Sahin, Ismail ^a   Sengezer, Mustafa ^a   Serdar, Muhittin ^a   Ifran, Ahmet ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Burn injury; IL 1; Systemic inflammatory response; Thalidomide; TNF

Indexed keywords

INTERLEUKIN 1; THALIDOMIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; MALE; NONHUMAN; PHAGOCYTE; RAT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BURNS; DRUG EVALUATION, PRECLINICAL; INTERLEUKIN-1; MALE; RATS; RATS, SPRAGUE-DAWLEY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38049162049     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2007.01.007     Document Type: Article

References (23)

1. Huang Y.S., Yang Z.C., Lius X.S., Chen F.M., He B.B., Li A., et al. Serial experimental and clinical studies on the pathogenesis of multiple organ dysfunction syndrome in severe burns. Burns 24 (1998) 706-716
2. Sheridan R.L., Ryan C.M., Yin L.M., Hurley C., and Tompkins R.G. Death in the burn unit: sterile multiple organ failure. Burns 24 (1998) 307-311
3. Arturson G. Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995. Burns 1 (1996) 309-319
4. Arturson G. Neutrophil granulocyte functions in severely burned patients. Burns 11 (1985) 309-319
5. Klebanoff S.J., Vadas M.A., Harlan J.M., Sparks L.H., Gamble J.R., Agosti J.M., et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 136 (1986) 4220-4225
6. Liu X.-S., Luo Z.-C., Yang Z.-C., Huang W.-H., and Li A. The significance of changes in serum tumor, necrosis factor activity in severely burned patient. Burns 20 (1994) 40-44
7. Lowry S.F. Cytokine mediators of immunity and inflammation. Arch Surg 128 (1993) 1235-1241
8. Sparkes B.G. Immunological responses to thermal injury. Burns 23 (1996) 106-113
9. Cioffi W.C., Burleson D.G., and Pruitt B.A. Leukocyte responses to injury. Arch Surg 112 (1992) 860-865
10. Hinder F, Traber DL. Pathophysiology of the systemic inflammatory responses syndrome. In: Herndorn, D, editor. Total burn care, 1st ed. Philadelphia: WB Saunders, 1996. p. 207.
11. Eski M., Deveci M., Celikoz B., Nisanci M., and Turegun M. Treatment with cerium nitrate bathing modulate systemic leukocyte activation following burn injury: an experimental study in rat cremaster muscle flap. Burns 27 (2001) 739-746
12. Sampio E.P., Kaplan G., Sarno E.N., Galilly R., and Cohn Z.A. Thalidomide selectively inhibits tumor necrosis factor alfa production by simulated human monocytes. J Exp Med 173 (1991) 699-703
13. Mreira A.L., Sampio E.P., Zmuidzinas A., Frindt P., Smith K.A., and Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor ( by enhancing mRNA degradation. J Exp Med 177 (1993) 1675-1680
14. Sampio E.P., Sarno E.N., Miranda A., Nery J.A.C., Miguel C.P., Viana S.M., et al. The influence of thalidomide on the clinical and immunological manifestation of erythema nodosum leprosum. J Infect Dis 168 (1993) 408-414
15. Erikson T., Björkman S., and Höglund P. Clinical pharmacology of thalidomide. Eur J Clin Pharmacol 57 (2001) 365-376
16. Deveci M., Eski M., Sengezer M., and Ki{dotless}sa U. Effects of cerium nitrate bathing and prompt burn wound excision on IL-6 and TNF-alpha levels in burned rats. Burns 26 (2000) 41-45
17. Endo S., Inada K., Yamada Y., Kasai T., and Nakea H. Plasma tumor necrosis factor-α (TNF-α) levels in patients with burns. Burns 19 (1993) 124-127
18. Nakea H., Endo S., Yamada Y., and Inada K. Bound and soluble adhesion molecule and cytokine levels in patients with severe burns. Burns 26 (2000) 139-144
19. Yeh T.S., Ho Y.P., Huang S.F., Yeh J.N., Jan Y.Y., and Chen M.F. Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats. J Hepatol 41 (2004) 606-612
20. Allgower M., Schoenenberger G., and Sparkes B. Burning the largest organ. Burns 21 Suppl. 1 (1995) 7-47
21. Schneider J., Bruckmann W., and Zwingenberger K. Extravasation of leukocytes assessed by intravital microscopy: effect of thalidomide. Inflamm Res 46 (1997) 392-397
22. Nogueira A.N., Neubert R., Felies A., Jacob-Muller U., Frankus E., and Neubert D. Thalidomide derivatives and the immune system. 6. Effects of two derivatives with no obvious teratogenic potency on the pattern of integrins and other surface receptors on blood cells marmosets. Life Sci 58 (1995) 337-348
23. Finnerty C.C., Herndon D.N., Przkora R., Pereira C.T., Oliveria H.M., Queiroz D.M.M., et al. Cytokine expression profile over time in severely burned pediatric patients. Shock 26 (2006) 13-19